These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 27974829)
1. Evidence for a LOS and a capsular polysaccharide in Capnocytophaga canimorsus. Renzi F; Ittig SJ; Sadovskaya I; Hess E; Lauber F; Dol M; Shin H; Mally M; Fiechter C; Sauder U; Chami M; Cornelis GR Sci Rep; 2016 Dec; 6():38914. PubMed ID: 27974829 [TBL] [Abstract][Full Text] [Related]
2. Capsular serovars of virulent Capnocytophaga canimorsus are shared by the closely related species C. canis and C. cynodegmi. Renzi F; Hess E; Dol M; Koudad D; Carlier E; Ohlén M; Moore E; Cornelis GR Emerg Microbes Infect; 2018 Jul; 7(1):124. PubMed ID: 29970924 [TBL] [Abstract][Full Text] [Related]
3. Capnocytophaga canimorsus resists phagocytosis by macrophages and blocks the ability of macrophages to kill other bacteria. Meyer S; Shin H; Cornelis GR Immunobiology; 2008; 213(9-10):805-14. PubMed ID: 18926295 [TBL] [Abstract][Full Text] [Related]
4. Escape from immune surveillance by Capnocytophaga canimorsus. Shin H; Mally M; Kuhn M; Paroz C; Cornelis GR J Infect Dis; 2007 Feb; 195(3):375-86. PubMed ID: 17205476 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Capnocytophaga canimorsus in dogs and occurrence of potential virulence factors. Mally M; Paroz C; Shin H; Meyer S; Soussoula LV; Schmiediger U; Saillen-Paroz C; Cornelis GR Microbes Infect; 2009 Apr; 11(4):509-14. PubMed ID: 19285152 [TBL] [Abstract][Full Text] [Related]
6. Only a subset of C. canimorsus strains is dangerous for humans. Renzi F; Dol M; Raymackers A; Manfredi P; Cornelis GR Emerg Microbes Infect; 2015 Aug; 4(8):e48. PubMed ID: 26421271 [TBL] [Abstract][Full Text] [Related]
7. Identification of Virulent Capnocytophaga canimorsus Isolates by Capsular Typing. Hess E; Renzi F; Koudad D; Dol M; Cornelis GR J Clin Microbiol; 2017 Jun; 55(6):1902-1914. PubMed ID: 28381610 [No Abstract] [Full Text] [Related]
8. Complete genome sequence of the dog commensal and human pathogen Capnocytophaga canimorsus strain 5. Manfredi P; Pagni M; Cornelis GR J Bacteriol; 2011 Oct; 193(19):5558-9. PubMed ID: 21914877 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Capnocytophaga canimorsus and Capnocytophaga cynodegmi in dogs and cats determined by using a newly established species-specific PCR. Suzuki M; Kimura M; Imaoka K; Yamada A Vet Microbiol; 2010 Jul; 144(1-2):172-6. PubMed ID: 20144514 [TBL] [Abstract][Full Text] [Related]
10. Characterization of three strains of Capnocytophaga canis isolated from patients with sepsis. Suzuki M; Imaoka K; Haga Y; Mohri M; Nogami A; Shimojima Y; Irie Y; Sugimura S; Morikawa S Microbiol Immunol; 2018 Sep; 62(9):567-573. PubMed ID: 30118139 [TBL] [Abstract][Full Text] [Related]
11. Improvement of identification of Capnocytophaga canimorsus by matrix-assisted laser desorption ionization-time of flight mass spectrometry using enriched database. Magnette A; Huang TD; Renzi F; Bogaerts P; Cornelis GR; Glupczynski Y Diagn Microbiol Infect Dis; 2016 Jan; 84(1):12-15. PubMed ID: 26508105 [TBL] [Abstract][Full Text] [Related]
13. Distribution of Capnocytophaga canimorsus in dogs and cats with genetic characterization of isolates. Umeda K; Hatakeyama R; Abe T; Takakura K; Wada T; Ogasawara J; Sanada S; Hase A Vet Microbiol; 2014 Jun; 171(1-2):153-9. PubMed ID: 24745627 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of Capnocytophaga canimorsus and other canine Capnocytophaga spp. and assessment by PCR of their frequencies in dogs. van Dam AP; van Weert A; Harmanus C; Hovius KE; Claas EC; Reubsaet FA J Clin Microbiol; 2009 Oct; 47(10):3218-25. PubMed ID: 19641058 [TBL] [Abstract][Full Text] [Related]
15. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies. Choi EH; Zhang F; Lu YJ; Malley R Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201 [TBL] [Abstract][Full Text] [Related]
16. Resistance of Capnocytophaga canimorsus to killing by human complement and polymorphonuclear leukocytes. Shin H; Mally M; Meyer S; Fiechter C; Paroz C; Zaehringer U; Cornelis GR Infect Immun; 2009 Jun; 77(6):2262-71. PubMed ID: 19307219 [TBL] [Abstract][Full Text] [Related]
17. Fatal Capnocytophaga canimorsus (DF-2) septicaemia. A case report. Linton DM; Potgieter PD; Roditi D; Phillips A; Adams BK; Hayhurst M; Knobel GJ S Afr Med J; 1994 Dec; 84(12):857-60. PubMed ID: 7570239 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsus. Hack K; Renzi F; Hess E; Lauber F; Douxfils J; Dogné JM; Cornelis GR J Thromb Haemost; 2017 Mar; 15(3):487-499. PubMed ID: 28029716 [TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of bacterial polysaccharides in drug-resistant enterococci. Ali L; Blum HE; Sakιnç T Glycoconj J; 2019 Oct; 36(5):429-438. PubMed ID: 31230165 [TBL] [Abstract][Full Text] [Related]
20. The genome and surface proteome of Capnocytophaga canimorsus reveal a key role of glycan foraging systems in host glycoproteins deglycosylation. Manfredi P; Renzi F; Mally M; Sauteur L; Schmaler M; Moes S; Jenö P; Cornelis GR Mol Microbiol; 2011 Aug; 81(4):1050-60. PubMed ID: 21762219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]